Angiotensin II Receptor Blockers Inhibit the Generation of Epoxyeicosatrienoic Acid from Arachidonic Acid in Recombinant CYP2C9, CYP2J2 and Human Liver Microsomes-Reference-Cited by-同舟云学术

Angiotensin II Receptor Blockers Inhibit the Generation of Epoxyeicosatrienoic Acid from Arachidonic Acid in Recombinant CYP2C9, CYP2J2 and Human Liver Microsomes

Published:2017-05-10 Issue:4 Volume:121 Page:239-245
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Senda Asuna¹,Mukai Yuji¹,Hayakawa Toru²,Kato Yuka¹,Eliasson Erik³,Rane Anders³,Toda Takaki¹,Inotsume Nobuo¹

Affiliation:

1. Division of Clinical Pharmacology; Hokkaido Pharmaceutical University School of Pharmacy; Sapporo Hokkaido Japan

2. Division of Pharmacotherapy; Hokkaido Pharmaceutical University School of Pharmacy; Sapporo Hokkaido Japan

3. Division of Clinical Pharmacology; Department of Laboratory Medicine; Karolinska University Hospital; Karolinska Institute; Stockholm Sweden

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12789/fullpdf

Reference48 articles.

1. Epoxygenase pathways of arachidonic acid metabolism;Zeldin;J Biol Chem,2001

2. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids;Node;Science,1999

3. Functional vasodilation in the rat spinotrapezius muscle: role of nitric oxide, prostanoids and epoxyeicosatrienoic acids;Xiang;Clin Exp Pharmacol Physiol,2008

4. The epoxyeicosatrienoic acid pathway enhances hepatic insulin signaling and is repressed in insulin-resistant mouse liver;Schäfer;Mol Cell Proteomics,2015

5. Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury;Khan;Front Pharmacol,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain;Current Opinion in Pharmacology;2024-10

2. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control;Pharmacology & Therapeutics;2024-06

3. Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review;Drug Metabolism Reviews;2024-03-20

4. Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions;British Journal of Clinical Pharmacology;2022-06-08

5. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors;European Journal of Pharmaceutical Sciences;2021-09